The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy.
about
Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month resultsSpectral-domain optical coherence tomography findings in polypoidal choroidal vasculopathy suggest a type 1 neovascular growth pattern.Idiopathic polypoidal choroidal vasculopathy: a disease with diverse clinical spectrum and systemic associations.Polypoidal choroidal vasculopathy in Chinese patients.The origins of polypoidal choroidal vasculopathyAngiographic lesion of polypoidal choroidal vasculopathy on indocyanine green and fluorescein angiography.Argon laser photocoagulation for the treatment of polypoidal choroidal vasculopathy.Clinical features of early and late stage polypoidal choroidal vasculopathy characterized by lesion size and disease duration.Cystoid macular edema in polypoidal choroidal vasculopathy viewed by a scanning laser ophthalmoscope: CME in PCV viewed by SLO.Comparison between 1-year outcomes of aflibercept with and without photodynamic therapy for polypoidal choroidal vasculopathy: Retrospective observation study.Clinical features, management and visual outcome of polypoidal choroidal vasculopathy in Indian patients.Characteristics of age-related macular degeneration in patients with diabetic retinopathy.Three major loci involved in age-related macular degeneration are also associated with polypoidal choroidal vasculopathy.Association between hyperacuity defects and retinal microstructure in polypoidal choroidal vasculopathyPolypoidal choroidal vasculopathy and history of central serous chorioretinopathy.Idiopathic polypoidal choroidal vasculopathy in a young man: case report and literature review.Effectiveness of intravitreal ranibizumab in exudative age-related macular degeneration (AMD): comparison between typical neovascular AMD and polypoidal choroidal vasculopathy over a 1 year follow-up.Time-lag between subretinal fluid and pigment epithelial detachment reduction after polypoidal choroidal vasculopathy treatmentA hyporeflective space between hyperreflective materials in pigment epithelial detachment and Bruch's membrane in neovascular age-related macular degenerationPattern of presentation of idiopathic polypoidal choroidal vasculopathy in Ibadan, Sub-Saharan Africa.Prospective evaluation of subretinal vessel location in polypoidal choroidal vasculopathy (PCV) and response of hemorrhagic and exudative PCV to high-dose antiangiogenic therapy (an American Ophthalmological Society thesis).TOMM40 rs2075650 polymorphism shows no association with neovascular age-related macular degeneration or polypoidal choroidal vasculopathy in a Chinese population.C2 rs547154 polymorphism and polypoidal choroidal vasculopathy susceptibility: a meta-analysis.Future therapies of wet age-related macular degeneration.The association of elastin gene variants with two angiographic subtypes of polypoidal choroidal vasculopathy.Development of polypoidal lesions in age-related macular degenerationEn face imaging of the choroid in polypoidal choroidal vasculopathy using swept-source optical coherence tomography.Polypoidal choroidal vasculopathy in exudative and haemorrhagic pigment epithelial detachments.Gene-gene interaction of CFH, ARMS2, and ARMS2/HTRA1 on the risk of neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in Chinese populationPolypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation.1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathyDifferent transitions of multifocal electroretinogram recordings between patients with age-related macular degeneration and polypoidal choroidal vasculopathy after photodynamic therapy.Intravitreal bevacizumab and ranibizumab injections for patients with polypoidal choroidal vasculopathyCOL8A1 rs13095226 polymorphism shows no association with neovascular age-related macular degeneration or polypoidal choroidal vasculopathy in Chinese subjects.The Features of Inflammation Factors Concentrations in Aqueous Humor of Polypoidal Choroidal VasculopathyIs age-related macular degeneration a problem in Ibadan, Sub-Saharan Africa?Systemic steroids as an aid to the management of Idiopathic Polypoidal Choroidal Vasculopathy (IPCV): A descriptive analysis.Polypoidal choroidal vasculopathy appearing as classic choroidal neovascularisation on fluorescein angiographyShort-term effectiveness of intravitreal bevacizumab vs. ranibizumab injections for patients with polypoidal choroidal vasculopathyCOL1A2 polymorphic markers confer an increased risk of neovascular age-related macular degeneration in a Han Chinese population.
P2860
Q27311334-0B207A11-CB33-43BF-8C0D-DA24C15CC1D6Q30410747-384B9DA6-0B7F-4D75-A649-561A4ABD3888Q30634073-981C8C4C-4789-4B69-AC42-09B1A41700DEQ31098011-33899FFD-D1FA-48CD-806E-04F50083A98DQ33214094-639ED64F-955E-4E53-A43B-7A797CD1FD6EQ33277543-CE505F00-4D42-4319-BD70-811137FC16E0Q33295175-CB3AE9C5-A3EB-428C-A680-5A7BB771981EQ33301645-FCB73EA6-7F1A-4CCD-834D-7707F17F6C24Q33375951-AD03EC35-71AB-408B-8B3E-0EF014486257Q33632486-D31C0C4D-FC01-4F76-958D-CC3F0F45F99FQ33650784-FFAEEE39-450C-42AB-8B09-1E2A96C32316Q33888124-AC16A816-6BDE-4A0E-AB2F-FFF6BA86DB18Q33982669-F16612ED-A632-4882-B05C-01FD3169AE14Q34039123-8B6C5CCD-7758-4569-9789-368EA5F971DBQ34055052-EC63A4A4-224D-42D0-A12C-5A19CAB3AA14Q34570373-CA8FDB20-60CA-4E52-A617-FA9FED7D8CBBQ34655439-8666AB80-53AB-4E7A-A586-226D23135884Q34695085-81B7097C-CCE9-4005-A347-E006AF324E12Q34761868-8B9E9788-26CB-450D-940D-F4722306EDD6Q34844667-1EB7C3C4-3183-4B4E-8B74-8D78403854E0Q35018542-E521B186-19FC-49A0-A2AC-BF219BFCF466Q35022261-AA7FF5FA-0E45-467B-9CAF-90078FC0BC77Q35138698-4FEAAA8C-4842-43A9-A71C-CA933B28C3EDQ35162495-682FFD8E-5762-48E7-93E4-E3E67CF6A073Q35182156-C5A6E057-6ABE-4A5A-9C29-AF0A390D7B82Q35208778-ED06EF49-80EA-4732-829C-34BB694D2D85Q35289120-F06B8E3F-47E4-4272-8155-37864430850EQ35314391-C60C01B9-48F2-44E7-A119-F801CCD9DAA6Q35577431-B6C842E2-FEEF-4DE3-B19B-A39612E5B084Q35589482-813CA6D7-0A20-436C-A339-8C7D42623E3AQ35677770-66B86470-4EFE-4C7A-B545-3324C1569AC5Q35762763-236CF1C0-4FBC-42C6-AA13-C486A5AE71C4Q35820349-1827528E-62A9-4A95-BF4D-3F2419C00A09Q35855286-E08C0697-95B7-48EF-8165-9C00AF316374Q35901243-544745AF-596F-4E48-B7C5-08DBFF0D4503Q35906378-9D80E260-7D80-416D-B80D-318A614B3FC7Q35947415-EC04A83D-A46F-46E3-A194-159109370B49Q35954073-360F8BDB-FA05-4FB3-A537-FED02E19D4D8Q35999201-41224975-1E89-42FC-8812-A8C7287101A0Q36099674-7341D509-3BE9-49A1-8029-BEFB8438A713
P2860
The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy.
@en
type
label
The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy.
@en
prefLabel
The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy.
@en
P2093
P1433
P1476
The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy.
@en
P2093
A Ciardella
D A Orlock
K B Freund
L A Yannuzzi
R F Spaide
P304
P356
10.1001/ARCHOPHT.1997.01100150480005
P407
P577
1997-04-01T00:00:00Z